SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-5.4%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$3.27B
AUM Growth
+$3.27B
(-37%)
Cap. Flow
-$1.5B
Cap. Flow
% of AUM
-45.92%
Top 10 Holdings %
Top 10 Hldgs %
36.77%
Holding
111
New
16
Increased
19
Reduced
19
Closed
23
Top Buys
| 1 |
Centene
CNC
|
$101M |
| 2 |
Visa
V
|
$97.1M |
| 3 |
Las Vegas Sands
LVS
|
$88.4M |
| 4 |
S&P Global
SPGI
|
$84.8M |
| 5 |
Charles Schwab
SCHW
|
$82.9M |
Top Sells
| 1 |
Adobe
ADBE
|
$222M |
| 2 |
Amazon
AMZN
|
$205M |
| 3 |
Analog Devices
ADI
|
$144M |
| 4 |
Quanta Services
PWR
|
$133M |
| 5 |
Cencora
COR
|
$133M |
Sector Composition
| 1 | Healthcare | 47.04% |
| 2 | Consumer Discretionary | 18.58% |
| 3 | Financials | 10.68% |
| 4 | Industrials | 10.44% |
| 5 | Technology | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Hilton Worldwide
HLT
$64.9B
| $55M | 1.68% |
362,703
-236,319
| -39% | -$35.9M |
|
27
Marriott International Class A Common Stock
MAR
$72.7B
| $54.3M | 1.66% |
309,240
-184,400
| -37% | -$32.4M |
|
28
Energy Select Sector SPDR Fund
XLE
$27.7B
| $53M | 1.62% |
+692,868
| New | +$53M |
|
29
Bath & Body Works
BBWI
$6.09B
| $49.6M | 1.52% |
+1,038,630
| New | +$49.6M |
|
30
Marqeta
MQ
$2.77B
| $44.7M | 1.37% |
4,049,950
+2,582,582
| +176% | +$28.5M |
|
|
MRTX
31
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $42M | 1.28% |
510,331
+107,542
| +27% | +$8.84M |
|
32
Deckers Outdoor
DECK
$18.2B
| $39M | 1.19% |
142,477
-73,753
| -34% | -$20.2M |
|
33
Ultragenyx Pharmaceutical
RARE
$2.89B
| $38.1M | 1.16% |
525,100
+39,858
| +8% | +$2.89M |
|
34
EyePoint Pharmaceuticals
EYPT
$797M
| $35.3M | 1.08% |
2,909,407
+389,707
| +15% | +$4.73M |
|
35
Agios Pharmaceuticals
AGIO
$2.28B
| $34.3M | 1.05% |
1,177,374
| – | – |
|
36
Insmed
INSM
$30.7B
| $31M | 0.95% |
1,318,432
+236,900
| +22% | +$5.57M |
|
37
Sutro Biopharma
STRO
$80.6M
| $30.7M | 0.94% |
3,732,400
+1,294,605
| +53% | +$10.6M |
|
38
McKesson
MCK
$85.4B
| $30M | 0.92% |
+97,980
| New | +$30M |
|
39
Wynn Resorts
WYNN
$13B
| $29.2M | 0.89% |
+366,060
| New | +$29.2M |
|
|
MRNS
40
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $25.9M | 0.79% |
2,766,000
+127,225
| +5% | +$1.19M |
|
41
KalVista Pharmaceuticals
KALV
$678M
| $25.7M | 0.79% |
1,746,300
| – | – |
|
|
PNT
42
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $24M | 0.73% |
3,014,408
+341,545
| +13% | +$2.72M |
|
43
Natera
NTRA
$23.1B
| $23.8M | 0.73% |
584,660
-51,500
| -8% | -$2.1M |
|
|
KDNY
44
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $23.5M | 0.72% |
1,434,200
+186,732
| +15% | +$3.05M |
|
45
Kezar Life Sciences
KZR
$28.9M
| $23.4M | 0.72% |
1,409,956
| – | – |
|
|
CANO
46
DELISTED
Cano Health, Inc.
CANO
| $23.3M | 0.71% |
3,668,478
-6,204,512
| -63% | -$39.4M |
|
47
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.92B
| $22.2M | 0.68% |
+164,970
| New | +$22.2M |
|
48
Arcellx
ACLX
$3.87B
| $21.5M | 0.66% |
+1,533,059
| New | +$21.5M |
|
49
Xenon Pharmaceuticals
XENE
$3.03B
| $21.2M | 0.65% |
692,000
| – | – |
|
50
Heron Therapeutics
HRTX
$202M
| $16.4M | 0.5% |
2,869,048
+382,708
| +15% | +$2.19M |
|